Correction: Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2.

Correction: J Exp Clin Cancer Res 38, 495 (2019)

https://doi.org/10.1186/s13046-019-1488-1

Following publication of the original article [1], an error was identified in Fig. 8; specifically:

Fig. 8

hBMSCs-derived exosomal miR-205 inhibits LNCaP cell proliferation, invasion, and migration and enhances apoptosis. a proliferation of LNCaP cells treated with hBMSCs and miR-205 measured using EdU assay (× 200); b apoptosis of LNCaP cells treated with hBMSCs and miR-205 measured using flow cytometry; Abscissa represents apoptotic cells identified by Annexin V-FITC and ordinate represents dead cells identified by PI; c invasion and migration of LNCaP cells treated with hBMSCs and miR-205 measured using Transwell assay (× 200); d protein band patterns and levels of Ki67, PCNA, MMP-2, MMP-9, Bcl-2, and Bax measured in LNCaP cells treated with hBMSCs and miR-205 determined using western blot analysis; *, p < 0.05. Measurement data were expressed as mean ± standard deviation; comparisons between two groups were analyzed using unpaired t-test; the experiment was repeated 3 times independently

Fig. 8C: Incorrect image used for migration experiment of exo-miR-NC (bottom left image); correct image is now used.

The corrected figure is given here. The correction does not have any effect on the final conclusions of the paper.